An Open Label, Multi-centre, Non-interventional Post-marketing Surveillance (PMS) to Monitor the Safety and Efficacy of ZIAGEN [Rm] Administered in Korean Patients According to the Prescribing Information

Trial Profile

An Open Label, Multi-centre, Non-interventional Post-marketing Surveillance (PMS) to Monitor the Safety and Efficacy of ZIAGEN [Rm] Administered in Korean Patients According to the Prescribing Information

Completed
Phase of Trial: Phase IV

Latest Information Update: 25 Sep 2015

At a glance

  • Drugs Abacavir (Primary) ; Antiretrovirals
  • Indications HIV-1 infections
  • Focus Adverse reactions
  • Sponsors GlaxoSmithKline; ViiV Healthcare
  • Most Recent Events

    • 22 Sep 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 28 Feb 2011 Additional trial investigator (Cheri Hudson) identified as reported by ClinicalTrials.gov.
    • 18 Feb 2011 Actual initiation date (Nov 2010) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top